Multiple Manufacturers

Ondansetron

Manufacturer:

Multiple Manufacturers

Ondansetron HCPCS:

Q0162

HCPCS Code Descriptor:

Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

Category:

Q Code

Ondansetron NDCs:

00904-7073-93, 16714-0671-02, 00904-6552-61, 00904-6551-61, 00781-5239-64, 68001-0247-17, 00781-1681-31, 00378-7734-93, 68001-0247-04, 16714-0201-30, 00781-5239-80, 68001-0246-17, 00781-5238-64, 68462-0158-13, 68001-0246-04, 00378-7732-93, 51672-4091-03, 16714-0200-30, 67877-0170-30, 55111-0154-30, 68462-0157-13, 55111-0153-30, 67877-0169-30, 16714-0160-01, 00378-7734-97, 16714-0159-01, 68462-0106-30, 68462-0158-11, 16714-0201-10, 68462-0105-30, 00781-1681-33

Primary Type:

Oncology-Anti-Emetic

Generic/Specialty Status:

Multi-Source

Route of Administration:

Oral

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00781-5239-64, 00781-1681-31, 00781-5239-80, 00781-5238-64, 67877-0170-30, 67877-0169-30, 00781-1681-33

About Ondansetron:

Ondansetron is an Oncology-Anti-Emetic drug manufactured by A-S Medication Solutions and administered via the Oral route of administration. The Q Code: Q0162 is aligned to the drug Ondansetron.

ACCESS PRICING AND MORE BY REGISTERING

Q0162 Added Date:

January 1, 2012

Q0162 Effective Date:

January 1, 2012

Q0162 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ondansetron billing and coding information.
Our team did not identify a source for Ondansetron patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for Ondansetron
Our team has not yet identified a source of side effects information for Ondansetron. Please check back in a few weeks.